Search

everythinglearnresearchcommunity

for

Search:↓

The mutant HR bmh protein affects hair follicle formation by failing to repress vitamin D receptor activity.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

High ODC and low K1 and K10 may indicate early skin tumors in mice.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Lactobacillus paracasei HY7015 helps hair grow in mice.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Basal cell carcinoma shows keratin patterns similar to hair follicle structures.

NFIB and STAT5 work together to control specific genetic programs in cells.

WNT10A is important for tissue development and linked to various human disorders.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

S100A4 and S100A6 proteins may activate stem cells for hair follicle regeneration and could be potential targets for hair loss treatments.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

KY19382 helps to regrow hair and create new hair follicles.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.